Diane M. Simeone

General Surgery

3855 Health Sciences Dr
La Jolla, CA 92093

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 161 publications

Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE Consortium.

Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE Consortium.

Journal: International journal of cancer

Published: February 27, 2026

BASECAMP-1 screening study: a model for efficient enrolment in precision oncology clinical trials.

BASECAMP-1 screening study: a model for efficient enrolment in precision oncology clinical trials.

Journal: BMJ oncology

Published: December 16, 2025

Pancreatic MRI Findings in High-Risk Individuals Compared with Matched Average-Risk Individuals.

Pancreatic MRI Findings in High-Risk Individuals Compared with Matched Average-Risk Individuals.

Journal: Pancreas

Published: December 08, 2025

Pancreatic MRI Findings in High-Risk Individuals Compared With Matched Average-Risk Individuals.

Pancreatic MRI Findings in High-Risk Individuals Compared With Matched Average-Risk Individuals.

Journal: Pancreas

Published: December 08, 2025

Targeting FSP1 triggers ferroptosis in lung cancer.

Targeting FSP1 triggers ferroptosis in lung cancer.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2025

UPF1 deficiency enhances mitochondrial ROS which promotes an immunosuppressive microenvironment in pancreatic ductal adenocarcinoma.

UPF1 deficiency enhances mitochondrial ROS which promotes an immunosuppressive microenvironment in pancreatic ductal adenocarcinoma.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 01, 2025

Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma.

Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma.

Journal: Gastroenterology

Published: June 24, 2025

A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individuals.

A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individuals.

Journal: Cancers

Published: May 09, 2025

Nectin-4 reduces T cell effector function and is a therapeutic target in pancreatic cancer.

Nectin-4 reduces T cell effector function and is a therapeutic target in pancreatic cancer.

Journal: JCI insight

Published: April 07, 2025

Recurrent BEND2 Fusion Genes Identified by Whole Transcriptome Sequencing of Nonfunctional Pancreatic Neuroendocrine Tumors Correlate With Poor Patient Prognosis.

Recurrent BEND2 Fusion Genes Identified by Whole Transcriptome Sequencing of Nonfunctional Pancreatic Neuroendocrine Tumors Correlate With Poor Patient Prognosis.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: March 17, 2025

Clonal Heterogeneity in Human Pancreatic Ductal Adenocarcinoma and Its Impact on Tumor Progression.

Clonal Heterogeneity in Human Pancreatic Ductal Adenocarcinoma and Its Impact on Tumor Progression.

Journal: bioRxiv : the preprint server for biology

Published: February 24, 2025

Identification of patients at risk for pancreatic cancer in a 3-year timeframe based on machine learning algorithms.

Identification of patients at risk for pancreatic cancer in a 3-year timeframe based on machine learning algorithms.

Journal: Scientific reports

Published: August 29, 2024

Showing 1-12 of 161

Last Updated: 09/26/2026